The Therapeutics Pipeline Program (TPP) funds promising Parkinson’s disease (PD) therapies from preclinical through clinical testing. By providing strategic investment at critical development points, ...

We’re thrilled to be back for another year at Carson Beach! Whether you walk, run, volunteer, or cheer from the sidelines, your participation helps fuel progress and brings us closer to a cure.

Our trial matching tool connects you with recruiting studies to speed science. Search now to find studies based on your location and health history. No login is required. Want to be notified when new ...

Our experts discuss sexual changes in men and women with Parkinson's, how the disease and its impact affects intimate relationships, and what strategies and treatments can help. Register to watch on ...

There is a genetic component to Parkinson’s, with researchers estimating that about 30 percent of Parkinson’s risk is explained by genetics. Less than 10 percent of this risk has been explained by ...

The Michael J. Fox Foundation for Parkinson’s Research invites you to our free educational event for people with Parkinson’s and their loved ones. Join us in Washington, D.C. on October 24, 2026 at ...

Donna Krenicki believes in momentum. Whether she’s hiking, golfing or spending the day with her young grandchildren (five under the age of 5), movement has always been central to her life. It’s how ...

In my conversations with people and families living with Parkinson’s disease (PD), I’m always humbled and grateful to be taught something new. This blog is the result of an important conversation I ...

As part of The Michael J. Fox Foundation’s goal to support the development of new and better Parkinson’s treatments, we are regularly assessing and tracking the drug development pipeline. Five areas ...

A new report released on March 26, 2026, by The Michael J. Fox Foundation (MJFF) shows that the annual economic impact of Parkinson’s disease and atypical parkinsonisms in the United States reached ...